Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 10, 1999, Pages 1041-1050

  Husemann, Kim ^a   Wolter, Marietta ^a,b   Büschges, Rainer ^b   Boström, Jan ^b   Sabel, Michael ^a   Reifenberger, Guido ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Brain neoplasms; CDKN2C; Chromosome 1; Deletion mapping; Mutation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CHROMOSOME 1; CHROMOSOME DELETION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN CELL; MALE; OLIGODENDROGLIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0032858569     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199910000-00002     Document Type: Article

References (37)

1. Reifenberger G, Kros JM, Schiffer D, Collins VP. Oligodendroglial tumours and mixed gliomas. In: Kleihues P, Cavenee WK, eds. Pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 1997:37-48
2. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol I994;145:1175-90
3. Bello MJ, Leone PE, Vaquero J, et al. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer 1995;64:207-10
4. Zhu JJ, Santarius T, Wu X, et al. Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas. Genes Chromosomes Cancer 1998;21:207-16
5. Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995;54:91-95
6. Maintz D, Fiedler K, Koopmann J, et al. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997;56:1098-104
7. Rosenberg JE, Lisle DK., Burwick JA, et al. Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene 1995;13:2483-85
8. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Develop 1994;8:2939-52
9. Kleihues P, Burger PC, Scheithauer B. Histological typing of tumours of the central nervous system. Berlin: Springer-Verlag 1993;16-19
10. INK4a, MTS1) and CDK4 gene have frequent mutations of the retinoblastoma gene. Oncogene 1996;13:1065-72
11. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 1989;9.17-9.19
12. Reifenberger J, Ring GU, Gies U, et al. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 1996;55:824-33
13. Jensen SJ, Sulman EP, Maris JM, et al. An integrated transcript map of human chromosome 1p35-p36. Genomics 1997;42:126-36
14. Boström J, Mühlbauer A, Reifenberger G. Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to DIS496 in human meningiomas. Acta Neuropathol (Berl.) 1997;94:479-85
15. Blais A, Labrie Y, Pouliot F, Lachance Y, Labrie C. Structure of the gene encoding the human cyclin-dependent kinase inhibitor p18 and mutational analysis in breast cancer. Biochem Biophys Res Commun 1998;247:146-53
16. Lapointe J, Lachance Y, Labrie Y, Labrie C. A p18 mutant defective in CDK6 binding in human breast cancer cells. Cancer Res 1996;56:4586-89
17. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res 1995;55:1448-51
18. Weber RG, Sabel M, Reifenberger J, et al. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 1996;13:983-94
19. Bello MJ, Vaquero J, de Campos JM, et al. Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors. Int J Cancer 1994;57:172-75
20. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473-79
21. Bello MJ, Leone PE, Nebreda P, et al. Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet 1995;83:160-64
22. Schwab M, Praml C, Amler L. Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer 1996,16:211-29
23. Vance JM, Matise TC, Wooster R, et al. Report of the third international workshop on human chromosome 1 mapping 1997. Cytogenet Cell Genet 1997;78:154-82
24. Martinsson T, Sjöberg RM, Hallstensson K, Nordling M, Hedborg F, Kogner P. Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours. Eur J Cancer 1997;33:1997-2001
25. White PS, Maris JM, Sulman EP, et al. Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma. Eur J Cancer 1997;33:1957-61
26. Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-19
27. Maris JM, Jensen SJ, Sulman EP, et al. Cloning, chromosomal localization, physical mapping, and genomic characterization of HKR3. Genomics 1996;35:289-98
28. Mai M, Huang H, Reed C, et al. Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1p-arm deletions. Genomics 1998;51:359-63
29. Maris JM, Jensen J, Sulman EP, et al. Human Kruppel-related 3 (HKR3): A candidate for the Ip36 neuroblastoma tumour suppressor gene? Eur J Cancer 1997;33:1991-96
30. Sulman EP, Dumanski JP, White PS, et al. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity. Cancer Res 1998;58:3226-30
31. Schleiermacher G, Peter M, Michon J, et al. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer 1994;10:275-81
32. Chen Q, Yang CY, Tsan JT, et al. Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. J Exp Med 1990;172:1403-8
33. Praml C, Finke LH, Herfarth C, Schlag P, Schwab M, Amler L. Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 1995;11:1357-62
34. Iolascon A, Faienza MF. Coppola B, della Ragione F, Schettini F, Biondi A. Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias. Leukemia 1996;10:255-60
35. Tasaka T, Berenson J, Vescio R, et al. Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma. Br J Haematol 1997;96:98-102
36. INK4 mutations. Nat Struct Biol 1998;5:74-81
37. Hirai H, Roussel MF, Kato J-Y, Ashmun RA, Sherr CJ. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 1995;15:2672-81